Exelixis
EXEL
#1644
Rank
HK$81.00 B
Marketcap
HK$283.66
Share price
0.64%
Change (1 day)
60.28%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company